Repligen
RGEN
Earnings for Repligen (RGEN)
Earnings in 2023 (TTM): $66.08 M
According to Repligen 's latest financial reports the company's current earnings (TTM) are $36.72 M. a decrease over its 2022 earnings that were of $0.22 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Repligen from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | $66.08 M | -70% |
| 2022 | $0.22 B | 33.37% |
| 2021 | $0.16 B | 131.52% |
| 2020 | $71.35 M | 101.31% |
| 2019 | $35.44 M | 25.93% |
| 2018 | $28.14 M | 105.61% |
| 2017 | $13.68 M | -11.46% |
| 2016 | $15.46 M | 14.91% |
| 2015 | $13.45 M | 20.26% |
| 2014 | $11.18 M | -51.49% |
| 2013 | $23.06 M | 90.98% |
| 2012 | $12.07 M | |
| 2010 | $0.17 M | -103.81% |
| 2009 | -$4.59 M | -223.84% |
| 2008 | $3.7 M | |
| 2006 | -$2.49 M | 229.64% |
| 2005 | -$0.76 M | -89.16% |
| 2004 | -$6.97 M | -16.86% |
| 2003 | -$8.38 M | 88.72% |
| 2002 | -$4.44 M | -27.88% |
| 2001 | -$6.16 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $3.26 B | 8,795.61% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $6.29 B | 17,048.61% | 🇺🇸 USA |
 General Electric GE | $6.69 B | 18,121.42% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | -$5.85 B | -16,017.88% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | -$0.12 B | -424.00% | 🇺🇸 USA |
 Novavax NVAX | -$0.53 B | -1,539.35% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $0.47 B | 1,192.54% | 🇺🇸 USA |
 Bio-Techne TECH | $0.26 B | 623.60% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.23 B | 546.28% | 🇺🇸 USA |
 Charles River Laboratories
CRL | $0.58 B | 1,482.76% | 🇺🇸 USA |